163 related articles for article (PubMed ID: 3139428)
21. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
Akhras F; Hellestrand K; Whalley D; Jackson G
Int J Cardiol; 1994 Mar; 43(3):251-6. PubMed ID: 8181883
[TBL] [Abstract][Full Text] [Related]
22. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
23. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris.
Georgopoulos AJ; Markis A; Georgiadis H
Eur J Clin Pharmacol; 1982; 22(6):481-5. PubMed ID: 6813126
[TBL] [Abstract][Full Text] [Related]
25. Comparison of placebo, nitroglycerin, and isosorbide dinitrate for effectiveness of relief of angina and duration of action.
Kattus AA; Alvaro AB; Zohman LR; Coulson AH
Chest; 1979 Jan; 75(1):17-23. PubMed ID: 105834
[TBL] [Abstract][Full Text] [Related]
26. Double-blind, randomized study of the anti-anginal and anti-ischaemic efficacy of fendiline and diltiazem in patients with coronary heart disease.
Schulz J; Lubnau E; Grossmann M; Rück W
Curr Med Res Opin; 1991; 12(8):521-39. PubMed ID: 1764956
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
Brügmann U; Blasini R; Rudolph W
Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
[TBL] [Abstract][Full Text] [Related]
28. A comparison of sublingual nifedipine versus nitroglycerin in the treatment of acute angina pectoris.
Mooss AN; Mohiuddin SM; Hilleman DE; Sketch MH
DICP; 1989; 23(7-8):562-4. PubMed ID: 2503945
[TBL] [Abstract][Full Text] [Related]
29. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
[TBL] [Abstract][Full Text] [Related]
31. Clinical studies with transdermal nitroglycerin.
Hollenberg M; Go M
Am Heart J; 1984 Jul; 108(1):223-31. PubMed ID: 6428209
[TBL] [Abstract][Full Text] [Related]
32. The effects of felodipine in angina pectoris.
Lorimer AR; MacFarlane P; Pringle S; Barbour MP; Fox Y; Lawrie TD
Eur J Clin Pharmacol; 1990; 38(5):415-9. PubMed ID: 2116311
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
34. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
Rezaković DE; Lakatos S; Stalec J; Pavicić L
Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
[TBL] [Abstract][Full Text] [Related]
35. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
[TBL] [Abstract][Full Text] [Related]
37. The effect of timolol vs placebo on angina pectoris.
Aronow WS; Turbow M; Van Camp S; Lurie M; Whittaker K
Circulation; 1980 Jan; 61(1):66-9. PubMed ID: 6765920
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral sustained-release nitroglycerin on exercise capacity in angina pectoris: dose-response relation and duration of action during double-blind crossover randomized acute therapy.
Degré SG; Strappart GM; Sobolski JC; Berkenboom GM; Stoupel EE; Vandermoten PP
Am J Cardiol; 1983 Jun; 51(10):1595-8. PubMed ID: 6407293
[TBL] [Abstract][Full Text] [Related]
39. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
40. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
Fox KM; Dargie HJ; Deanfield J; Maseri A
Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
